Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Andrillon%2C+Ana%C3%AFs%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Andrillon%2C+Ana%C3%AFs%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Andrillon%2C+Ana%C3%AFs%22&type=Person&sort=year
PubPharm (11)
1
Dose optimization for cancer treatments with considerations for late-onset toxicities
enthalten in:
Clinical trials (London, England)
| 2024
von
Biard, L.
|
Andrillon, A.
|
Silva, R.
| +1
Wird geladen...
2
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment
enthalten in:
Journal of biopharmaceutical statistics
| 2023
von
Andrillon, A.
|
Biard, L.
|
Lee, S.
Wird geladen...
3
Surv-CRM-12 : A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression
enthalten in:
Statistics in medicine
| 2022
von
Andrillon, A.
|
Chevret, S.
|
Lee, S.
| +1
Wird geladen...
4
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome
enthalten in:
The British journal of dermatology
| 2022
von
Roelens, M.
|
de Masson, A.
|
Andrillon, A.
| +8
Wird geladen...
5
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis : A Multicenter Study of 330 Patients
enthalten in:
American journal of ophthalmology
| 2022
von
Maalouf, G.
|
Andrillon, A.
|
Leclercq, M.
| +18
Wird geladen...
6
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema : A Multicenter Study from the French Uveitis Network
enthalten in:
Ophthalmology
| 2022
von
Leclercq, M.
|
Andrillon, A.
|
Maalouf, G.
| +15
CommentIn: Ophthalmology. 2022 Jul;129(7):e77. - PMID 35346510
Wird geladen...
7
Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
enthalten in:
British Journal of Dermatology
| 2022
von
Roelens, M.
|
Masson, A.
|
Andrillon, A.
| +8
Wird geladen...
8
Surv‐CRM‐12 : A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression
enthalten in:
Statistics in Medicine
| 2022
von
Andrillon, A.
|
Chevret, S.
|
Lee, S.
| +1
Wird geladen...
9
Dose-finding design and benchmark for a right censored endpoint
enthalten in:
Journal of biopharmaceutical statistics
| 2020
von
Andrillon, A.
|
Chevret, S.
|
Lee, S.
| +1
Wird geladen...
10
Performance of propensity score matching to estimate causal effects in small samples
enthalten in:
Statistical methods in medical research
| 2020
von
Andrillon, A.
|
Pirracchio, R.
|
Chevret, S.
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
11
Aufsätze
11
E-Artikel
11
E-Ressourcen
Zeitschriftentitel
3
Journal of biopharmaceutical statistics
1
American journal of ophthalmology
1
British Journal of Dermatology
1
Clinical trials (London, England)
1
Ophthalmology
1
Statistical methods in medical research
1
Statistics in Medicine
1
Statistics in medicine
1
The British journal of dermatology
Alle anzeigen ...
weniger ...
Thema
8
Journal Article
3
competing risks
3
survival data
2
Antibodies, Monoclonal, Humanized
2
Antineoplastic Agents
2
Dose-finding
2
Multicenter Study
2
Observational Study
2
Tumor Necrosis Factor Inhibitors
2
Tumor Necrosis Factor-alpha
2
benchmark
2
dose-finding
2
late-onset toxicity
2
oncology
2
treatment discontinuation
1
Accelerated dose finding
1
Adalimumab
1
Anti–tumor necrosis factor α agents
1
B72HH48FLU
1
Bayesian adaptive dose finding
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
1
2023
6
2022
3
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...